Evaluation of assay interference and interpretation of CXCR4 receptor occupancy results in a preclinical study with MEDI3185, a fully human antibody to CXCR4
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of assay interference and interpretation of CXCR4 receptor occupancy results in a preclinical study with MEDI3185, a fully human antibody to CXCR4
Authors
Keywords
-
Journal
CYTOMETRY PART B-CLINICAL CYTOMETRY
Volume 90, Issue 2, Pages 209-219
Publisher
Wiley
Online
2015-09-19
DOI
10.1002/cyto.b.21327
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multifunctional human CD56low CD16low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients
- (2015) H. Stabile et al. HAEMATOLOGICA
- Multifunctional human CD56low CD16low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients
- (2015) H. Stabile et al. HAEMATOLOGICA
- Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition
- (2015) Edward Allan R. Sison et al. Oncotarget
- Anti-IL21 receptor monoclonal antibody (ATR-107): Safety, pharmacokinetics, and pharmacodynamic evaluation in healthy volunteers: A phase I, first-in-human study
- (2013) Fei Hua et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
- (2012) Narendra Chirmule et al. AAPS Journal
- A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
- (2012) G. L. Uy et al. BLOOD
- A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
- (2012) Paul J Rutgeerts et al. GUT
- Bioanalytical Approaches to Quantify “Total” and “Free” Therapeutic Antibodies and Their Targets: Technical Challenges and PK/PD Applications Over the Course of Drug Development
- (2011) Jean W. Lee et al. AAPS Journal
- A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes
- (2011) EG Stefanich et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells
- (2011) A Dar et al. LEUKEMIA
- PK–PD modeling of protein drugs: implications in assay development
- (2011) Lorin K Roskos et al. Bioanalysis
- Phenotype, Distribution and Alloreactive Properties of Memory T Cells from Cynomolgus Monkeys
- (2010) Ognjenka Nadazdin et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Recommendations for the validation of flow cytometric testing during drug development: I instrumentation
- (2010) Cherie L. Green et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Recommendations for the validation of flow cytometric testing during drug development: II assays
- (2010) Denise M. O'Hara et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1
- (2009) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Belatacept-Mediated Costimulation Blockade Through Evaluation of CD80/86-Receptor Saturation
- (2009) Robert Latek et al. TRANSPLANTATION
- Structural characterization of a human Fc fragment engineered for lack of effector functions
- (2008) Vaheh Oganesyan et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started